TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers report that weaker, slower beta-band activity was associated with sensory timing difficulties, disorganized speech and more severe clinical symptoms in a small schizophrenia study. The findings suggest a possible shared brain process, but do not establish a diagnostic test or prove that the signal causes symptoms.
Researchers report that weaker, slower beta-band brain activity was associated with sensory timing difficulties, disorganized speech and greater clinical symptom severity among people with schizophrenia. The study, published in Science Advances, suggests that features often examined separately may share a brain process, but its small sample does not establish that the signal causes symptoms or can diagnose the condition.
The researchers compared 25 people diagnosed with schizophrenia with 25 healthy participants. Using high-resolution magnetoencephalography, or MEG, they measured brain activity while participants completed tasks testing how accurately they judged the timing of visual and auditory information. The team also analyzed participants’ speech for signs of disorganized thinking and communication.
The schizophrenia group showed weaker and slower beta-band activity than the control group. Within the group with schizophrenia, people with more pronounced abnormalities in the signal also tended to have greater difficulty judging the timing of sights and sounds, more disorganized speech and more severe clinical symptoms, the report said. Beta-band activity refers to rhythmic electrical patterns involved in coordinating brain processes, including perception and movement.
The study was conducted by researchers affiliated with McGill University, the McConnell Brain Imaging Centre, the University of Montreal, the Research Centre of the University of Montreal Health Centre and the Douglas Research Centre. The MEG scans were performed at the McConnell Brain Imaging Centre at the Montreal Neurological Institute-Hospital, known as The Neuro.
A Possible Link Across Symptom Types
Schizophrenia can affect how a person perceives the world, moves and communicates. These features are often investigated as distinct symptoms. The reported association offers a possible way to study whether disruptions in the brain’s processing of information contribute to several of them at once, rather than each arising through an entirely separate process.
The result is a research lead, not a clinical tool. If larger studies reproduce the association, beta-band measurements could help researchers investigate who may need additional support, including young people seeking help for mental health concerns. The authors also suggest the signal could be studied as a possible treatment target. Neither early identification nor treatment use has been established by this study.
Products Worth Considering
Theragun Relief Massage Gun, 3-Speed, Black
Therabody Theragun Relief Massage Gun, 3 Speeds, Navy
Levoit Vital 100S-P Air Purifier for Home and Pets
As an affiliate, we earn on qualifying purchases.
How Researchers Measured Brain Activity
The team focused on beta-band rhythms because they are involved in coordinating information processing, including perception and movement. The brain continually uses sensory input to develop and update its understanding of its surroundings; the researchers propose that disruption in this process may help explain why symptoms can span several areas of behavior.
MEG detects the small magnetic fields generated by electrical activity in the brain. Its timing precision allowed the researchers to examine brain signals as participants processed sights and sounds. The study’s speech analysis and clinical assessments then let the team compare the signal with communication patterns and symptom severity. Those comparisons found associations, but they cannot show whether the brain signal contributes to the symptoms, results from them or is related to another factor.
Small Sample, Open Questions
The study included 50 participants, so it remains unclear how reliably the observed associations would appear in larger and independent groups. The report does not establish whether beta-band changes cause sensory, speech or clinical difficulties, or whether they are specific to schizophrenia rather than shared with other conditions.
It is also unknown whether the signal can distinguish individuals who will develop psychosis from those who will not. The researchers describe early identification as a potential future application, not a result demonstrated by this study. No diagnostic threshold, clinical test or treatment based on the signal was established.
Replication Before Clinical Use
The next step is testing the findings in larger, independent samples, with particular attention to whether beta-band abnormalities consistently track speech disruption and overall symptom severity. Such studies would also need to establish how specific and reliable the signal is before researchers could assess its value for identifying people who may need support.
Further research could examine whether beta-band activity is a useful target for treatment studies, as Wei suggested. For now, the finding adds a possible shared mechanism for investigation; the available evidence does not support using MEG beta-band measurements to diagnose schizophrenia or guide care.
Key Questions
What brain signal did the study examine?
The researchers measured beta-band activity, rhythmic brain activity involved in coordinating processes such as perception and movement.
What symptoms were associated with the signal?
More pronounced signal abnormalities were associated with greater difficulty judging the timing of sights and sounds, more disorganized speech and more severe clinical symptoms among participants with schizophrenia.
Does the finding mean beta-band activity causes schizophrenia symptoms?
No. The study found associations; it did not establish that the signal causes symptoms or show whether the changes result from symptoms or another factor.
Can this signal be used to diagnose schizophrenia now?
No diagnostic test was established. The researchers said larger, independent studies are needed before the signal’s reliability or potential clinical use can be assessed.
Source: sciencedaily.com
